Clinical trial · Interventional
Short-term Effect of a New Nordic Renal Diet on Phosphorus Homeostasis in CKD Stage 3-4
NCT03472105CI-TRIAL-00041616completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Hyperphosphatemia is a severe complication to chronic kidney disease (CKD) and is associated with increased risk of vascular calcification, cardiovascular morbidity and mortality. Early dietary intervention and improvement in dietary therapy might optimally reduce cardiovascular complications. For this purpose the investigators investigated patients with CKD stage 3-4, the participants dietary habits, developed a New Nordic Renal Diet and investigated the short term effect on phosphorus homeostasis.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Chronic Kidney Disease, Stage 3 (Moderate) | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| New Nordic Renal Diet | Dietary Supplement | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- OTHER
- label
- Habitual diet
- description
- 18 participants were on a habitual diet for 7 days
- interventionNames
- Dietary Supplement: New Nordic Renal Diet
- type
- ACTIVE_COMPARATOR
- label
- New Nordic Renal Diet
- description
- 18 participants were given a New Nordic Renal Diet for 7 days
- interventionNames
- Dietary Supplement: New Nordic Renal Diet
Primary outcomes (1)
- measure
- 24-hour urine phosphorus excretion
- timeFrame
- 7 days
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Estimated glomerular filtration rate (eGFR) 16 to 45 ml/min/1.73 m2, as judged by CKD-EPI equation * Medically stable for 2 months before and during the study * No food allergies * Ability to understand the Danish language orally and in writing Exclusion Criteria: \- Intake of phosphate binders
References
Publications (0)
Data not yet available
No reference posted for this study.